Medicinal Product Shortages – update – 29 May 2019
Notice type: Advisory
Date: 29/05/2019
Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Alendronic acid & Colecalciferol Teva 70mg/5600IU Tablet – PA0749/196/002
- Co-Amoxiclav 500mg/100mg Powder for Solution for Injection and Infusion - PA1457/001/001
- Detrusitol 1mg Film Coated Tablet – PA0822/213/001
- Detrusitol 2mg Film Coated Tablet – PA0822/213/002
- Fosavance 70mg/5600IU Tablet – EU/1/05/310/007
- Fybogel Mebeverine Granules for oral Suspension – PA0979/010/001
- Fybogel Orange 3.5mg Granules (30 pack only) – PA0979/009/002
- Letrozole Accord 2.5mg Film Coated Tablet - PA2315/109/001
- Neoclarityn 5mg Tablet – EU/1/00/161/011
- Oxynorm 5mg Capsules – PA1688/006/004
- Oxynorm Dispera 5mg Orodispersable Tablet – PA1688/006/007
- Solpadol Effervescent 500mg/30mg Tablet – PA0540/159/003
- Surmontil 50mg Capsules – PA0540/128/003
- Zestan 10mg Tablet – PA0126/112/003
- Zestan 20mg Tablet – PA0126/112/004
The following shortage has been resolved and supply has resumed to the Irish market:
- Co-Amoxiclav Teva 500mg/100mg Powder for Solution for Injection or Infusion – PA0749/011/001
- Denzapine 50mg/ml Oral Suspension - PA126/235/005
- Mirapexin 0.088mg Tablet – EU/1/97/051/001
- Valaciclovir Teva 500mg Film Coated Tablet - PA0749/036/001
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated in real time.
« Back